A looming U.S. deadline for more severe global tariffs is among a barrage of upcoming events threatening to disrupt an increasingly calm U.S. stock market that has set a string of all-time highs.

With 1 August fast approaching, we expect the Trump administration to announce pharmaceutical tariffs soon. We anticipate an initial tariff in the 10-25% range, with an announcement signalling a substantially higher rate to follow within 12 to 18 months.

From executive orders, bills passed to ongoing public arguments and more: here's how President Trump's second term has impacted Illinois so far.

Kia Corp. will adjust its business operations in the US and cut incentives for retail customers, joining carmakers globally in trying to mitigate the fallout of President Donald Trump’s import tariffs.

YETI Holdings is facing declining US sales amid a sharply elevated tariff profile that's cutting into outlook. Read why I downgrade YETI stock to a sell rating.

Confident that his right-wing populist policies would help win him favor with Trump’s administration, Orbán said in an interview in April that while tariffs “will be a disadvantage,” his government was negotiating “other economic agreements and issues that will offset them.”

General Motors said tariffs slashed its second-quarter income by more than $1 billion, and other companies pointed to import duties to explain smaller profits.

Cabrera, MCC Global Enterprise CEO, joins 'Squawk Box' to discuss the state of U.S. trade negotiations, impact of newly negotiated trade deals, U.S. trade talks with China and the EU, news of Chevron resuming oil production in Venezuela,